Bilaketaren emaitzak - Francis J. Giles

Findu emaitzak
  1. 1
    The Vascular Endothelial Growth Factor (VEGF) Signaling Pathway: A Therapeutic Target in Patients with Hematologic Malignancies

    The Vascular Endothelial Growth Factor (VEGF) Signaling Pathway: A Therapeutic Target in Patients with Hematologic Malignancies nork Francis J. Giles

    Argitaratua 2001
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Precision oncology for patients with advanced cancer: the challenges of malignant snowflakes

    Precision oncology for patients with advanced cancer: the challenges of malignant snowflakes nork Razelle Kurzrock, Francis J. Giles

    Argitaratua 2015
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Nuclear factor‐KappaB modulation as a therapeutic approach in hematologic malignancies

    Nuclear factor‐KappaB modulation as a therapeutic approach in hematologic malignancies nork Amit Panwalkar, Srđan Verstovšek, Francis J. Giles

    Argitaratua 2004
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Microtubule dynamics as a target in oncology

    Microtubule dynamics as a target in oncology nork April L. Risinger, Francis J. Giles, Susan L. Mooberry

    Argitaratua 2008
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Elraglusib (9-ING-41), a selective small-molecule inhibitor of glycogen synthase kinase-3 beta, reduces expression of immune checkpoint molecules PD-1, TIGIT and LAG-3 and enhances CD8+ T cell cytolytic killing of melanoma cells

    Elraglusib (9-ING-41), a selective small-molecule inhibitor of glycogen synthase kinase-3 beta, reduces expression of immune checkpoint molecules PD-1, TIGIT and LAG-3 and enhances... nork Gary Shaw, Ludimila Cavalcante, Francis J. Giles, Alison Taylor

    Argitaratua 2022
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    The yin and yang of nitric oxide in cancer progression

    The yin and yang of nitric oxide in cancer progression nork Anthony J. Burke, Francis Sullivan, Francis J. Giles, Sharon A. Glynn

    Argitaratua 2013
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Role of artificial intelligence in the care of patients with nonsmall cell lung cancer

    Role of artificial intelligence in the care of patients with nonsmall cell lung cancer nork Mohamad Rabbani, Jonathan Kanevsky, Kamran Kafi, Florent Chandelier, Francis J. Giles

    Argitaratua 2018
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Important Therapeutic Targets in Chronic Myelogenous Leukemia

    Important Therapeutic Targets in Chronic Myelogenous Leukemia nork Hagop M. Kantarjian, Francis J. Giles, Alfonso Quintás‐Cardama, Jorge E. Cortés

    Argitaratua 2007
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Analysis of Drug Development Paradigms for Immune Checkpoint Inhibitors

    Analysis of Drug Development Paradigms for Immune Checkpoint Inhibitors nork Denis L. Jardim, Débora De Melo Gagliato, Francis J. Giles, Razelle Kurzrock

    Argitaratua 2017
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Targeting HSP90 for cancer therapy

    Targeting HSP90 for cancer therapy nork Devalingam Mahalingam, Ronan Swords, Jennifer S. Carew, Steffan T. Nawrocki, Kapil N. Bhalla, Francis J. Giles

    Argitaratua 2009
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Current and emerging treatment options in chronic myeloid leukemia

    Current and emerging treatment options in chronic myeloid leukemia nork Elias Jabbour, Jorge E. Cortés, Francis J. Giles, Susan O’Brien, Hagop M. Kantarjian

    Argitaratua 2007
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Mutations in DNA repair genes are associated with increased neo-antigen load and activated T cell infiltration in lung adenocarcinoma

    Mutations in DNA repair genes are associated with increased neo-antigen load and activated T cell infiltration in lung adenocarcinoma nork Young Kwang Chae, Jonathan F. Anker, Preeti Bais, Sandeep Namburi, Francis J. Giles, Jeffrey H. Chuang

    Argitaratua 2017
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC)

    Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (... nork Young Kwang Chae, Ayush Arya, Wade T. Iams, Marcelo Cruz, Sunandana Chandra, Jaehyuk Choi, Francis J. Giles

    Argitaratua 2018
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  14. 14
    MK-0457, a novel kinase inhibitor, is active in patients with chronic myeloid leukemia or acute lymphocytic leukemia with the T315I BCR-ABL mutation

    MK-0457, a novel kinase inhibitor, is active in patients with chronic myeloid leukemia or acute lymphocytic leukemia with the T315I BCR-ABL mutation nork Francis J. Giles, Jorge E. Cortés, Dan Jones, Donald A. Bergstrom, Hagop M. Kantarjian, Steven J. Freedman

    Argitaratua 2006
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Prognostic significance of cellular vascular endothelial growth factor expression in chronic phase chronic myeloid leukemia

    Prognostic significance of cellular vascular endothelial growth factor expression in chronic phase chronic myeloid leukemia nork Srđan Verstovšek, Hagop M. Kantarjian, Taghi Manshouri, Jorge E. Cortés, Francis J. Giles, Anna Rogers, Maher Albitar

    Argitaratua 2002
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Clinical features, diagnostic challenges, and management strategies in checkpoint inhibitor-related pneumonitis

    Clinical features, diagnostic challenges, and management strategies in checkpoint inhibitor-related pneumonitis nork Sarah Chuzi, Fábio Távora, Marcelo Cruz, Ricardo Costa, Young Kwang Chae, Benedito A. Carneiro, Francis J. Giles

    Argitaratua 2017
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  17. 17
    Glycogen synthase kinase-3 beta inhibitors as novel cancer treatments and modulators of antitumor immune responses

    Glycogen synthase kinase-3 beta inhibitors as novel cancer treatments and modulators of antitumor immune responses nork İlyas Şahin, Aditya Eturi, André De Souza, Sahithi Pamarthy, Fabio Tavora, Francis J. Giles, Benedito A. Carneiro

    Argitaratua 2019
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  18. 18
    Molecular Pathways: Targeting IDO1 and Other Tryptophan Dioxygenases for Cancer Immunotherapy

    Molecular Pathways: Targeting IDO1 and Other Tryptophan Dioxygenases for Cancer Immunotherapy nork Lijie Zhai, Stefani Spranger, David C. Binder, Galina Gritsina, Kristen L. Lauing, Francis J. Giles, Derek A. Wainwright

    Argitaratua 2015
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  19. 19
    The role of gemtuzumab ozogamicin in acute leukaemia therapy

    The role of gemtuzumab ozogamicin in acute leukaemia therapy nork Apostolia M. Tsimberidou, Francis J. Giles, Elihu H. Estey, Susan O’Brien, Michael J. Keating, Hagop M. Kantarjian

    Argitaratua 2005
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  20. 20
    <i>BCR-ABL</i>alternative splicing as a common mechanism for imatinib resistance: evidence from molecular dynamics simulations

    <i>BCR-ABL</i>alternative splicing as a common mechanism for imatinib resistance: evidence from molecular dynamics simulations nork Tai‐Sung Lee, Wanlong Ma, Xi Zhang, Francis J. Giles, Jorge E. Cortés, Hagop M. Kantarjian, Maher Albitar

    Argitaratua 2008
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: